In this interview, Jennifer shares her experience of being diagnosed with bipolar disorder, taking lithium and antidepressants for years, and how the medications affected her health, career, and relationships. She talks about being hospitalized, the side effects she endured, and the challenges of losing her stability. Jennifer also explains how she eventually came off the medications, discovered her struggles were more connected to ADHD and trauma, and how she has now been living medication-free for six years

In this episode, psychiatrist Dr. Matt Bernstein (founder of ACCORD) explains why metabolic therapies—ketogenic nutrition, circadian alignment, exercise, and mind-body work—often improve energy, mood, sleep, focus, and even psychosis, while enabling safer deprescribing. We dig into why standard care so often fails to restore function; what ketogenic diets can do in severe illness; why incentives from Big Food, Big Pharma, and insurers sideline foundational lifestyle care; and what families can start doing right now—because real change is likely to be grassroots.

In this interview, Dr. Jeffrey Wiegers (BioReset Medical) explains what MUSE stem cells are, how they differ from traditional mesenchymal stem cells, and whether they might help after neurological injuries—concussion/TBI, stroke, chemo neuropathy, or protracted withdrawal (including PSSD). We also cover safety, side effects, why sourcing and good manufacturing practice matter, and new state-level pathways in the U.S.

https://www.bioresetmedical.com/

John and Dee Foster were severely harmed by benzodiazepines—yet instead of staying silent, they spent years fighting for change. Their persistence paid off: the new ASAM benzodiazepine deprescribing guidelines now formally acknowledge physical dependence, protracted withdrawal, the need for slow, patient-led tapers that can take months to years, the importance of shared decision-making, and the role of peer and non-drug supports.

John and Dee share what they won for patients, and why these guidelines could mark a turning point in holding the medical system accountable.

In this interview, Cooper Davis shares his 13-year journey on psychiatric medications: starting with Ritalin in high school, moving through nearly every stimulant, and eventually adding multiple other drugs. What began as a dramatic improvement in focus and grades slowly turned into tolerance, side effects, and a growing medication stack that hurt his health, relationships, and career.

He describes the moments that pushed him to quit, his withdrawal in a 12-step rehab, and the process of rebuilding life without medications. This is a candid look at both the benefits and costs of psychiatric drugs, and what life can look like after coming off.

Clinical psychologist Anders Sørensen shares his journey from traditional talk therapy to becoming a leading voice in psychiatric drug withdrawal. After realizing that medications were emotionally blunting his clients and preventing meaningful therapeutic work, Anders began researching safe tapering strategies.

Anders also discusses his new book Crossing Zero: The Art and Science of Coming and Staying Off Psychiatric Drugs, and shares practical insights from years of clinical experience, research, and collaboration with the withdrawal community.

What happens when legal marijuana leads to psychosis, addiction, and family collapse? In this powerful interview, Dr. Yosef speaks with Aubree Adams, founder of Every Brain Matters, whose son suffered from cannabis induced psychosis after using high-potency THC products like dabs. This is not “just weed” — it’s an industrialized drug that is hurting people, especially teens. Aubree shares her family's harrowing story of watching her son become delusional, suicidal, and hospitalized — all linked to marijuana use. She exposes how the cannabis industry, medical system, and public policy continue to mislead families while ignoring the clear science linking THC to psychosis, addiction, and long-term brain damage. We dive into misdiagnosis, lack of support, withdrawal, and the painful reality of parenting a teen through marijuana addiction. Whether you're a parent, a clinician, or someone questioning the safety of today's weed — you need to hear this.

In this conversation, Dr. Joanna Moncrieff discusses her book 'Chemically Imbalanced'. She argues that there is no compelling evidence for a chemical imbalance in depression and questions the continued prescription of antidepressants. We explore the interests of the pharmaceutical industry, the ethical implications of using drugs to mask symptoms, and the need for a paradigm shift in mental health treatment. We discuss the influence of the pharmaceutical industry on psychiatric literature and the defensive stance of the psychiatric profession against critical viewpoints.